HMB (β-Hydroxy β-methylbutyrate) for Elderly Sarcopenia and Recovery Multi-Target in 2025 Trial
WELLNESS

HMB (β-Hydroxy β-methylbutyrate) for Elderly Sarcopenia and Recovery Multi-Target in 2025 Trial

By Sophie · · Journal of Cachexia, Sarcopenia and Muscle 2025
KO | EN

HMB (β-Hydroxy β-methylbutyrate) at 3g/day for 12 weeks significantly improved muscle strength and gait speed in 90 elderly sarcopenia and pre-frail patients in a 2025 clinical trial. Core function recovery via leucine metabolite.

The Journal of Cachexia, Sarcopenia and Muscle 2025 RCT enrolled 90 patients aged 65~80 with sarcopenia (SARC-F ≥4 or gait speed <1m/s) for 12 weeks of HMB 3g/day. Leg strength +12%, gait speed +0.15m/s, sit-to-stand time -2.4s, creatine kinase (CK) -28%, protein synthesis markers improved. Additional effect over protein diet + exercise alone group.

What is HMB

HMB is a metabolite produced when leucine (essential amino acid) is broken down in the body. Chemical name β-Hydroxy β-methylbutyrate. Humans produce 0.2~0.4g HMB from 5~10g leucine intake. Supplement target dose (3g) hard to reach via diet (would need 60g+ leucine).

Active molecules:

  • HMB calcium salt (HMB-Ca): standard supplement form
  • HMB free acid (HMB-FA): faster absorption, some clinical use
  • Leucine 5~10g: dietary target (natural HMB generation)

Multi-Target Mechanisms

1. Protein Breakdown Inhibition (Core):

  • Partial ubiquitin-proteasome pathway inhibition
  • Muscle protein breakdown ↓
  • Most meaningful in sarcopenia/cachexia

2. Protein Synthesis Support (mTOR):

  • Leucine·HMB activate mTORC1
  • Protein synthesis signal

3. Muscle Membrane Stability:

  • Phospholipid stabilization
  • Post-exercise damage ↓
  • DOMS·CK reduction

4. Immune Support:

  • Lymphocyte activity + immune modulation
  • Elderly·recovering patient immune

5. Subtle Insulin Resistance:

  • Partial insulin sensitivity support

Who Benefits

HMB has subtle effect in protein-adequate young athletes, most effective in:

1. Elderly/Sarcopenia/Pre-frail:

  • Accelerated muscle protein breakdown
  • Protein diet + exercise + HMB matrix
  • Gait speed, strength, fall risk support

2. Recovery/Cachexia Patients:

  • Cancer cachexia
  • COPD
  • Chronic kidney disease
  • Post-surgery recovery

3. Fasted/Low-Carb Exercise + Muscle Preservation:

  • Muscle protection during dieting
  • Protein-deficient exercise

4. Beginner Exercisers:

  • Strong effect in 4~12 week exercise initiation
  • Subtle effect in trained exercisers

Clinical Data

  • Journal of Cachexia 2025 RCT 90 subjects 12 weeks: elderly strength +12%, gait +0.15m/s
  • Meta-analysis 2024: consistent elderly sarcopenia/cachexia effects
  • Trial 2023: chronic kidney disease sarcopenia support
  • Sports trials: subtle effect in young, strong effect in elderly

Cautions

  • HMB alone insufficient with protein-deficient diet: protein diet foundation + HMB supplement
  • Pregnancy/lactation: limited data, clinical evaluation
  • Kidney disease: clinical evaluation (protein metabolism burden)
  • Liver disease: clinical evaluation
  • Exercise + HMB is the answer: HMB without exercise weak
  • 3g/day is standard: 1g, 1.5g have trials but 3g most consistent

Synergy Matrix

  • Protein diet 1.2~1.6g/kg: foundation
  • Vitamin D + HMB: elderly matrix
  • Resistance exercise + HMB: core matrix
  • EAA + HMB: protein synthesis synergy
  • Creatine + HMB: elderly strength

Consumer Message

Elderly sarcopenia, chronic patient recovery, cachexia support beyond protein diet + exercise alone offers meaningful HMB option. Subtle effect in young trained exercisers; protein diet first. Elderly + protein diet + exercise + HMB matrix. Protein synthesis + breakdown inhibition dual. Spring 2026 exercise/strength matrix elderly option. Pregnancy/kidney/liver clinical evaluation.